http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06250442-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be92719b856db86c092cc233e9512ca2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03G15-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03G9-097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03G9-087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03G9-08
filingDate 1993-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cb28c1e566a74532d18dac28c50eee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95dbb269931e9020ebb41f705ad255b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb3c2d7c041105d6e6471ca3ba131753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6fd53958e12a4aabd4cc713fe05efa1
publicationDate 1994-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H06250442-A
titleOfInvention Development method
abstract (57) [Summary] [Object] The present invention is intended to achieve colorization, high image quality, and stability of toner developability with time, and long-term toner contamination / fusion on a developer carrier or a latent image carrier. To provide a developing method using a non-magnetic one-component toner that does not occur even when used. [Structure] A non-magnetic one-component developer composed of negative polarity toner particles is supplied and carried on a developer carrying body provided opposite to a latent image carrier composed of an organic photoconductor, and the carried negative polarity toner particles. In the developing method for developing the latent image on the latent image carrier by means of the above, the developer carrying member and the latent image carrier are rotated at a linear velocity of 2: 1 to 1: 1 and the negative polarity toner particles are used. As the toner particles, resin particles containing a binder resin having a softening point of 100 to 140 ° C., a colorant, and a polar control agent composed of a boron complex salt having a specific structure as a main component, and an external additive composed of oxide particles are used. use.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4849166-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105264442-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6187489-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5891600-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1530102-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6042979-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5965312-A
priorityDate 1993-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H049070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0484140-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62195679-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0470670-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5929258-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59231552-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59198470-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0519528-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62967-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6368853-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03112990-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135871623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449341488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416391341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447543224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID186342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID197077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415868938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54070354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9850060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448432009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080796
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3670169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447756586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421234269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420768023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450937109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447483388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454007995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454006091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458434036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 77.